Primary and secondary cutaneous CD 30 1 lymphoproliferative disorders : a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment

@inproceedings{BekkenkPrimaryAS,
  title={Primary and secondary cutaneous CD 30 1 lymphoproliferative disorders : a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment},
  author={Marcel W. Bekkenk and Françoise A. M. J. Geelen and Pieter C. van Voorst Vader and Freerk Heule and M. -L. Geerts and Willem A. van Vloten and Chris J L M Meijer}
}
To evaluate our diagnostic and therapeutic guidelines, clinical and long-term follow-up data of 219 patients with primary or secondary cutaneous CD30 1 lymphoproliferative disorders were evaluated. The study group included 118 patients with lymphomatoid papulosis (LyP; group 1), 79 patients with primary cutaneous CD301 large T-cell lymphoma (LTCL; group 2), 11 patients with CD30 1 LTCL and skin and regional lymph node involvement (group 3), and 11 patients with secondary cutaneous CD30 1 LTCL… CONTINUE READING
Highly Influential
This paper has highly influenced 16 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 124 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 33 references

Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma

  • RD Gascoine, P Aoun, D Wu
  • Blood
  • 1999

Similar Papers

Loading similar papers…